Le Lézard
Classified in: Health, Business
Subject: CXP

Pelorus Equity Group's Pelorus Fund Announces Record Year of Growth and Returns


NEWPORT BEACH, Calif., Feb. 21, 2020 /PRNewswire/ -- Pelorus Equity Group, a cannabis-focused investment bank that specializes in providing value-add lending secured by real estate assets, today announced record growth for Pelorus Fund, its cannabis-focused commercial real estate fund that lends on commercial buildings and allows for cannabis-related tenants. The fund reported its most recent Q4 distribution of 20.4% and 15.5% internal rate of return (IRR) for 2019. Launched in 2018, the Pelorus Fund targets real estate-based financing opportunities with properly licensed and established cannabis businesses that have the required state and local operating licenses and permits. Pelorus has secured more than $150M in the pipeline for new cannabis-related closings this year.

Pelorus Equity Group, Inc. Logo

Coming off of a year of tremendous growth, Pelorus notably partnered with the Family Office Networks (FON) and their affiliated broker-dealer, Entoro Securities, to assist in the capital raise for the $100M Pelorus Fund. In addition to Pelorus Fund's 2019 returns, Pelorus Equity Group has also originated more than $65M in commercial loans with cannabis tenants since 2016.

"Pelorus Fund was able to gain significant returns and momentum despite last year's turbulent market," said Dan Leimel CEO of Pelorus. "We see a distinct demand for our cost-efficient real estate capital and are confident that our services can guide the industry through this period."

Pelorus has lent to provide the build-out for the tenants of some of the most visible CPG, medical and manufacturing companies in cannabis, including Canndescent, Growpacker, Harborside, Tikun Olam and a facility with one of the largest publicly traded pharmaceutical companies in the world.

ABOUT PELORUS EQUITY GROUP Pelorus Equity Group offers a range of innovative transactional solutions addressing the diverse needs of real estate investors and portfolio managers. Our flexible acquisition and bridge lending programs are the direct result of our involvement in more than 5,000 transactions of varying size and complexity. Since 1991, our principals have participated in more than $1 billion of real estate investment transactions using both debt and equity solutions. We draw on our extensive experience to rapidly understand an opportunity, structure a logical solution and execute a timely close.

Contact: Tori Rusko, [email protected]

SOURCE Pelorus Equity Group, Inc.


These press releases may also interest you

at 16:25
Precision BioSciences, Inc. , an advanced gene editing company, today announced the anticipated return of three programs from Prevail Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company. Precision exercised its option to regain...

at 16:25
AIDS Healthcare Foundation (AHF), the world's largest HIV/AIDS organization, is calling on public health officials to provide more education and prevention services around vaccinations as a new measles outbreak spreads through 17 U.S. states. As of...

at 16:19
Community research provider EmVenio Research and Prime Healthcare, an award-winning national health system, today announce their partnership to launch the EmVenio Research Center at Prime Healthcare. The partnership allows EmVenio to conduct research...

at 16:11
May 3rd to May 5th -- Get ready for a wave of fun and gratitude! Seventy-five amazing young international educators, therapists, nurses, and other care professionals are about to make a splash in San Clemente. These "Apex Care Professionals" are...

at 16:10
Exelixis, Inc. announced today that its first quarter 2024 financial results will be released on Tuesday, April 30, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss...

at 16:09
New research in the April 2024 issue of JNCCN?Journal of the National Comprehensive Cancer Network showcases the feasibility of...



News published on and distributed by: